NASDAQ:ATHX Athersys (ATHX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsSEC Filings About Athersys Stock (NASDAQ:ATHX) Get Athersys alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume4 shsAverage Volume1.77 million shsMarket Capitalization$833 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Athersys, Inc. was a biotechnology company focused on developing regenerative medicine products for serious and life-threatening conditions. Its primary platform was MultiStem, an investigational, allogeneic cell therapy derived from adult stem cells and designed for potential use without requiring a close donor-recipient tissue match. The company evaluated MultiStem in clinical programs targeting ischemic stroke, acute respiratory distress syndrome and other conditions involving tissue injury or inflammation. Athersys also pursued research collaborations and licensing arrangements, including a strategic relationship with Japan-based Healios K.K. to develop and commercialize MultiStem-based therapies in Japan. The product candidates remained investigational and were not approved therapies. Founded in 1995 and headquartered in Cleveland, Ohio, Athersys conducted research and clinical development activities in the United States and internationally through partners. The company entered Chapter 11 bankruptcy proceedings in 2023, and its business and assets subsequently underwent restructuring and disposition. Athersys was historically led by biotechnology executive Gil Van Bokkelen, who co-founded the company and served as its chief executive for many years.AI Generated. May Contain Errors. Read More Receive ATHX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Athersys and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ATHX Stock News HeadlinesAthersys, Inc. (ATHXQ)April 24, 2024 | finance.yahoo.comAthersys to Sell Most Assets to HealiosJanuary 8, 2024 | marketwatch.comElon says the ‘S’ wordElon Musk and Sam Altman have sued each other and feuded for years. Yet within days of one another, both men described the same moment in strikingly similar terms: a technological tipping point they call the Singularity. James Altucher says the idea once belonged to science fiction. Now he connects it to a move Musk could make as soon as October 21, and lays out what both men see coming in a short presentation.October 16 at 1:00 AM | Paradigm Press (Ad)Athersys Reports Third Quarter 2023 Financial Results and Business HighlightsNovember 16, 2023 | finance.yahoo.comAthersys shares migrate to Pink marketplace for broker-to-broker tradingOctober 23, 2023 | bizjournals.comAthersys shares delisted by Nasdaq Stock MarketOctober 20, 2023 | bizjournals.comAthersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic AlternativesOctober 16, 2023 | finance.yahoo.comAthersys crashes after bankruptcy warningOctober 10, 2023 | msn.comSee More Headlines ATHX Stock Analysis - Frequently Asked Questions How were Athersys' earnings last quarter? Athersys, Inc. (NASDAQ:ATHX) released its quarterly earnings data on Monday, November, 15th. The biopharmaceutical company reported ($1.75) earnings per share for the quarter, beating the consensus estimate of ($2.00) by $0.25. The biopharmaceutical company earned $4.79 million during the quarter. When did Athersys' stock split? Athersys's stock reverse split before market open on Monday, August 29th 2022.The 1-25 reverse split was announced on Monday, August 29th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. What other stocks do shareholders of Athersys own? Based on aggregate information from My MarketBeat watchlists, some other companies that Athersys investors own include Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), OPKO Health (OPK), Dynavax Technologies (DVAX), Bank of America (BAC), Novavax (NVAX) and Micron Technology (MU). Company Calendar Last Earnings11/15/2021Today10/15/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:ATHX CIK1368148 Webwww.athersys.com Phone(216) 431-9900Fax216-361-9495Employees24Year Founded1995Profitability EPS (Trailing Twelve Months)($2.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$72.53 million Net MarginsN/A Pretax Margin-46,304.93% Return on EquityN/A Return on Assets-223.03% Debt Debt-to-Equity RatioN/A Current Ratio0.06 Quick Ratio0.06 Sales & Book Value Annual Sales$146 thousand Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($1.33) per share Price / BookN/AMiscellaneous Outstanding Shares61,719,000Free Float61,700,000Market Cap$833 thousand OptionableNo Data Beta-0.90 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:ATHX) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersI have publicly predicted six major American crashes, before each one happened.Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredA simple options strategy that changed one trader's pathIan Cooper went from a financially stressed, struggling journalist to a trader who discovered a repeatable opt...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Athersys, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Athersys With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATHX Stock Alerts